Skip to contentSULLIVAN LOUIS W — UNITED THERAPEUTICS CORP insider: 443 transactions · InsiderLensSULLIVAN LOUIS W
- Director at BIOSANTE PHARMACEUTICALS INC · on record since Mar 20, 2006
- Director at 3M CO · on record since Feb 15, 2006
- Director at CIGNA CORP · on record since Jan 4, 2006
- Director at BRISTOL MYERS SQUIBB CO · on record since Jan 4, 2006
- Director at SCHEIN HENRY INC · on record since Mar 3, 2006
- Director at INHIBITEX, INC. · on record since Feb 2, 2006
- Director at UNITED THERAPEUTICS CORP · on record since Jul 10, 2006
- Director at Emergent BioSolutions Inc. · on record since Nov 21, 2006
- Director at EQUIFAX INC · on record since Jul 2, 2003
- Director at GEORGIA PACIFIC CORP · on record since Feb 3, 2004
Insider trading activity of SULLIVAN LOUIS W
- Transactions on record
- 443
- since Aug 13, 2003
- Open-market buys
- 2
- $43.9K
- Open-market sells
- 77
- $49.1M
- Companies traded
- 10
- last filing Dec 23, 2025
Figures computed from official regulatory filings — methodology.
Companies where SULLIVAN LOUIS W has traded
- UNITED THERAPEUTICS CORP203 tx · $65.4M · Dec 23, 2025
- Emergent BioSolutions Inc.82 tx · $10M · May 2, 2025
- SCHEIN HENRY INC63 tx · $13.3M · Apr 4, 2016
- BIOSANTE PHARMACEUTICALS INC22 tx · $43.9K · Mar 30, 2012
- INHIBITEX, INC.5 tx · $195.4K · Feb 15, 2007
- CIGNA CORP14 tx · $121.6K · Jun 1, 2006
- 3M CO13 tx · $60.4K · May 11, 2006
- BRISTOL MYERS SQUIBB CO22 tx · Apr 4, 2006
- GEORGIA PACIFIC CORP9 tx · Dec 28, 2005
- EQUIFAX INC
Track record of SULLIVAN LOUIS W
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of SULLIVAN LOUIS W
Co-insiders of SULLIVAN LOUIS W
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
10 tx · Jan 3, 2005
ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIPEmergent BioSolutions Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Dec 23, 2025 | Exercise | 3,230 | 183.98 USD | $594.3K | SEC |
| Dec 23, 2025 | ExerciseD | -3,230 | 0.00 USD | $0 | SEC |
| Dec 23, 2025 | ExerciseD | -2,720 | 0.00 USD | $0 | SEC |
| Dec 23, 2025 | Sell | -1,087 | 511.22 USD | $555.7K | SEC |
| Dec 23, 2025 | Exercise | 2,720 | 229.81 USD | $625.1K | SEC |
| Dec 23, 2025 | Sell | -4,863 | 512.34 USD | $2.5M | SEC |
| Jul 28, 2025 | AwardD | 1,830 | 0.00 USD | $0 | SEC |
| Jul 28, 2025 | ExerciseD | -590 | 0.00 USD | $0 | SEC |
| Jul 28, 2025 | AwardD | 650 | 0.00 USD | $0 | SEC |
| Jul 28, 2025 | Exercise | 590 | 0.00 USD | $0 | SEC |
| May 2, 2025 | Award | 34,403 | 0.00 USD | $0 | SEC |
| May 2, 2025 | AwardD | 15,824 | 0.00 USD | $0 | SEC |
| Dec 19, 2024 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Dec 19, 2024 | Sell | -620 | 381.41 USD | $236.5K | SEC |
| Dec 19, 2024 | Sell | -2,100 | 369.32 USD | $775.6K | SEC |
| Dec 19, 2024 | Sell | -800 | 381.37 USD | $305.1K | SEC |
| Dec 19, 2024 | Gift | -1,851 | 0.00 USD | $0 | SEC |
| Dec 19, 2024 | Sell | -2,200 | 375.00 USD | $825K | SEC |
| Dec 19, 2024 | Sell | -1,307 | 368.50 USD | $481.6K | SEC |
| Dec 19, 2024 | Sell | -944 | 379.67 USD | $358.4K | SEC |
| Dec 19, 2024 | Sell | -100 | 382.63 USD | $38.3K | SEC |
| Dec 19, 2024 | Sell | -1,121 | 366.11 USD | $410.4K | SEC |
| Dec 19, 2024 | Sell | -1,400 | 370.30 USD | $518.4K | SEC |
| Dec 19, 2024 | Exercise | 15,000 | 175.43 USD | $2.6M | SEC |
| Dec 19, 2024 | Sell | -1,962 | 374.17 USD | $734.1K | SEC |